{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:15:58Z","timestamp":1761822958384},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:00:00Z","timestamp":1168992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2007,3,6]]},"DOI":"10.1007\/s00381-006-0282-5","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T17:57:51Z","timestamp":1168970271000},"page":"407-413","source":"Crossref","is-referenced-by-count":11,"title":["Pilot study of ifosfamide\/carboplatin\/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma"],"prefix":"10.1007","volume":"23","author":[{"given":"Shuichi","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruaki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyoshi","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Ohzeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,17]]},"reference":[{"key":"282_CR1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","volume":"21","author":"RE Taylor","year":"2003","unstructured":"Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology\/United Kingdom Children\u2019s Cancer Study Group PNET-3 study. J Clin Oncol 21:1581\u20131591","journal-title":"J Clin Oncol"},{"key":"282_CR2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832\u2013845","journal-title":"J Clin Oncol"},{"key":"282_CR3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","volume":"17","author":"RJ Packer","year":"1999","unstructured":"Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children\u2019s Cancer Group study. J Clin Oncol 17:2127\u20132136","journal-title":"J Clin Oncol"},{"key":"282_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejca.2004.12.017","volume":"41","author":"RE Taylor","year":"2005","unstructured":"Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS (2005) Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP\/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727\u2013734","journal-title":"Eur J Cancer"},{"key":"282_CR5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.seminoncol.2004.07.009","volume":"31","author":"BR Rood","year":"2004","unstructured":"Rood BR, Macdonald TJ, Packer RJ (2004) Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol 31:666\u2013675","journal-title":"Semin Oncol"},{"issue":"Suppl 5","key":"282_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1398-2265.2004.00202.x","volume":"8","author":"SL Gardner","year":"2004","unstructured":"Gardner SL (2004) Application of stem cell transplant for brain tumors. Pediatr Transplant 8(Suppl 5):28\u201332","journal-title":"Pediatr Transplant"},{"issue":"Suppl 1","key":"282_CR7","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/annonc\/mdg702","volume":"14","author":"AD Zelenetz","year":"2003","unstructured":"Zelenetz AD, Hamlin P, Kewalramani T, Yahalom J, Nimer S, Moskowitz CH (2003) Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol 14(Suppl 1):i5\u2013i10","journal-title":"Ann Oncol"},{"key":"282_CR8","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.1999.17.12.3776","volume":"17","author":"CH Moskowitz","year":"1999","unstructured":"Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE, Hunte S, Coady-Lyons N, Agus DB, Goy A, Jurcic J, Noy A, O\u2019Brien J, Portlock CS, Straus DS, Childs B, Frank R, Yahalom J, Filippa D, Louie D, Nimer SD, Zelenetz AD (1999) Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin\u2019s lymphoma. J Clin Oncol 17:3776\u20133785","journal-title":"J Clin Oncol"},{"key":"282_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdf028","volume":"13","author":"AM Abu-Ghosh","year":"2002","unstructured":"Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS (2002) Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms\u2019 tumor: a Children\u2019s Cancer Group report. Ann Oncol 13:460\u2013469","journal-title":"Ann Oncol"},{"key":"282_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pbc.20227","volume":"44","author":"P Winkle Van","year":"2005","unstructured":"Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS (2005) Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent\/refractory sarcoma: the Children\u2019s Cancer Group (CCG) experience. Pediatr Blood Cancer 44:338\u2013347","journal-title":"Pediatr Blood Cancer"},{"key":"282_CR11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00381-003-0822-1","volume":"19","author":"E L\u00f3pez-Aguilar","year":"2003","unstructured":"L\u00f3pez-Aguilar E, Sep\u00falveda-Vild\u00f3sola AC, Rivera-M\u00e1rquez H, Cerecedo-Diaz F, Valdes-Sanchez M, Delgado-Huerta S, Wanzke-del Angel V, Ramon-Garcia G, Rodriguez-Jimenez H, Hernandez-Contreras I, Santacruz-Castillo E, Romo-Rubio HA (2003) Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children. Childs Nerv Syst 19:818\u2013823","journal-title":"Childs Nerv Syst"},{"key":"282_CR12","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(96)00299-7","volume":"32A","author":"M Sanson","year":"1996","unstructured":"Sanson M, Ameri A, Monjour A, Sahmoud T, Ronchin P, Poisson M, Delattre JY (1996) Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. Eur J Cancer 32A:2229\u20132235","journal-title":"Eur J Cancer"},{"key":"282_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.10375","volume":"42","author":"JF Loss","year":"2004","unstructured":"Loss JF, Santos PP, Leone LD, Brunetto AL (2004) Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide\/carboplatin\/etoposide (ICE): a phase II study in a pediatric oncology centre in Brazil. Pediatr Blood Cancer 42:139\u2013144","journal-title":"Pediatr Blood Cancer"},{"key":"282_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00043426-199508000-00009","volume":"17","author":"FH Kung","year":"1995","unstructured":"Kung FH, Desai SJ, Dickerman JD, Goorin AM, Harris MB, Inoue S, Krischer JP, Murphy SB, Pratt CB, Toledano S (1995) Ifosfamide\/carboplatin\/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I\/II study. J Pediatr Hematol Oncol 17:265\u2013269","journal-title":"J Pediatr Hematol Oncol"},{"key":"282_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"282_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2141.2003.04483.x","volume":"122","author":"S Fruehauf","year":"2003","unstructured":"Fruehauf S, Seggewiss R (2003) It\u2019s moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol 122:360\u2013375","journal-title":"Br J Haematol"},{"key":"282_CR17","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","volume":"18","author":"S Siena","year":"2000","unstructured":"Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C (2000) Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 18:1360\u20131377","journal-title":"J Clin Oncol"},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.2000.18.18.3319","volume":"18","author":"O Sezer","year":"2000","unstructured":"Sezer O, Possinger K, Metzner B, Illiger HJ, Wattad M, Heit W, Fuss H, Schultze W (2000) Optimal CD34 (+) cell dose in autologous peripheral-blood stem-cell transplantation. J Clin Oncol 18:3319\u20133320","journal-title":"J Clin Oncol"},{"key":"282_CR19","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/1097-0142(19901215)66:12<2465::AID-CNCR2820661204>3.0.CO;2-N","volume":"66","author":"PS Gaynon","year":"1990","unstructured":"Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD (1990) Carboplatin in childhood brain tumors. A Children\u2019s Cancer Study Group Phase II trial. Cancer 66:2465\u20132469","journal-title":"Cancer"},{"key":"282_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mpo.2950240309","volume":"24","author":"R Mastrangelo","year":"1995","unstructured":"Mastrangelo R, Lasorella A, Riccardi R, Colosimo C, Iavarone A, Tornesello A, Mastrangelo S, Ausili-Cefaro G, Di Rocco C (1995) Carboplatin in childhood medulloblastoma\/PNET: feasibility of an in vivo sensitivity test in an \u201cup-front\u201d study. Med Pediatr Oncol 24:188\u2013196","journal-title":"Med Pediatr Oncol"},{"key":"282_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2008-1071580","volume":"25","author":"R Boor","year":"1994","unstructured":"Boor R, Huber A, Gutjahr P (1994) Etoposide treatment in recurrent medulloblastoma. Neuropediatrics 25:39\u201341","journal-title":"Neuropediatrics"},{"key":"282_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1006333811437","volume":"45","author":"NL Kobrinsky","year":"1999","unstructured":"Kobrinsky NL, Packer RJ, Boyett JM, Stanley P, Shiminski-Maher T, Allen JC, Garvin JH (1999) Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children\u2019s Cancer Group study, CCG-9881. J Neurooncol 45:47\u201354","journal-title":"J Neurooncol"},{"key":"282_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mpo.2950210110","volume":"21","author":"P Chastagner","year":"1993","unstructured":"Chastagner P, Sommelet-Olive D, Kalifa C, Brunat-Mentigny M, Zucker JM, Demeocq F, Baranzelli MC, Tron P, Bergeron C, Pein F (1993) Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 21:49\u201353","journal-title":"Med Pediatr Oncol"},{"key":"282_CR24","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.1995.13.9.2247","volume":"13","author":"RL Heideman","year":"1995","unstructured":"Heideman RL, Kovnar EH, Kellie SJ, Douglass EC, Gajjar AJ, Walter AW, Langston JA, Jenkins JJ, Li Y, Greenwald C (1995) Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol 13:2247\u20132254","journal-title":"J Clin Oncol"},{"key":"282_CR25","first-page":"313","volume":"29","author":"E L\u00f3pez-Aguilar","year":"1998","unstructured":"L\u00f3pez-Aguilar E, Sep\u00falveda-Vild\u00f3sola AC, Rivera-M\u00e1rquez H, Cerecedo-Diaz F, Santacruz-Castillo E, Valdez-Sanchez M, Arias-Gomez J, Quintana-Roldan G (1998) Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy. Arch Med Res 29:313\u2013317","journal-title":"Arch Med Res"},{"key":"282_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","volume":"46","author":"RD Kortmann","year":"2000","unstructured":"Kortmann RD, K\u00fchl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sorensen N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT \u201991. Int J Radiat Oncol Biol Phys 46:269\u2013279","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"282_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2008-1043883","volume":"210","author":"J K\u00fchl","year":"1998","unstructured":"K\u00fchl J, M\u00fcller HL, Berthold F, Kortmann RD, Deinlein F, Maass E, Graf N, Gnekow A, Scheurlen W, Gobel U, Wolff JE, Bamberg M, Kaatsch P, Kleihues P, Rating D, Sorensen N, Wiestler OD (1998) Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT\u201988\/\u201989. Klin P\u00e4diatr 210:227\u2013233","journal-title":"Klin P\u00e4diatr"},{"key":"282_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s003810050543","volume":"15","author":"A Gajjar","year":"1999","unstructured":"Gajjar A, K\u00fchl J, Epelman S, Bailey C, Allen J (1999) Chemotherapy of medulloblastoma. Childs Nerv Syst 15:554\u2013562","journal-title":"Childs Nerv Syst"},{"key":"282_CR29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s004320050028","volume":"126","author":"P Gerke","year":"2000","unstructured":"Gerke P, Filejski W, Robins HI, Wiedemann GJ, Steinhoff J (2000) Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia. J Cancer Res Clin Oncol 126:173\u2013177","journal-title":"J Cancer Res Clin Oncol"},{"key":"282_CR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mpo.10336","volume":"41","author":"R Skinner","year":"2003","unstructured":"Skinner R (2003) Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 41:190\u2013197","journal-title":"Med Pediatr Oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-006-0282-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-006-0282-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-006-0282-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:29:55Z","timestamp":1559042995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-006-0282-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,17]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3,6]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s00381-006-0282-5","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,17]]}}}